BA's $3.5B Loss, NVO Weight Loss Drug Trial, AXP Down on Strong Earnings

"It's difficult to find what we're not liking" for American Express's (AXP) earnings, says Jenny Horne. A strong report bolstered by a big holiday shopping season wasn't enough to impress investors. Boeing (BA) gave its investors a heads up by noting a $3.5 billion cash flow loss for fourth quarter. Novo Nordisk (NVO) rallied after posting positive early-stage results for one of its weight loss drugs. Jenny takes a closer look into the market's reaction to these developing stories.

Morning Trade Live

24 Jan 2025

SHARE

Schwab Network's Newsletters

Daily insights for every investor